These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 26684393)
21. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia. Guo RJ; Atenafu EG; Schimmer AD; Minden MD; Chang H Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150 [TBL] [Abstract][Full Text] [Related]
22. Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction. Thanasopoulou A; Tzankov A; Schwaller J Haematologica; 2014 Sep; 99(9):1465-71. PubMed ID: 24951466 [TBL] [Abstract][Full Text] [Related]
23. High fms-like tyrosine kinase-3 (FLT3) receptor surface expression predicts poor outcome in Sharawat SK; Raina V; Kumar L; Sharma A; Bakhshi R; Vishnubhatla S; Gupta R; Bakhshi S Indian J Med Res; 2016 May; 143(Supplement):S11-S16. PubMed ID: 27748272 [TBL] [Abstract][Full Text] [Related]
24. NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis. Struski S; Lagarde S; Bories P; Puiseux C; Prade N; Cuccuini W; Pages MP; Bidet A; Gervais C; Lafage-Pochitaloff M; Roche-Lestienne C; Barin C; Penther D; Nadal N; Radford-Weiss I; Collonge-Rame MA; Gaillard B; Mugneret F; Lefebvre C; Bart-Delabesse E; Petit A; Leverger G; Broccardo C; Luquet I; Pasquet M; Delabesse E Leukemia; 2017 Mar; 31(3):565-572. PubMed ID: 27694926 [TBL] [Abstract][Full Text] [Related]
25. Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study. Miyamura T; Moritake H; Nakayama H; Tanaka S; Tomizawa D; Shiba N; Saito AM; Tawa A; Shimada A; Iwamoto S; Hayashi Y; Koike T; Horibe K; Manabe A; Mizutani S; Taga T; Adachi S Br J Haematol; 2019 Apr; 185(2):284-288. PubMed ID: 30784060 [TBL] [Abstract][Full Text] [Related]
26. Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group. Tarlock K; Alonzo TA; Loken MR; Gerbing RB; Ries RE; Aplenc R; Sung L; Raimondi SC; Hirsch BA; Kahwash SB; McKenney A; Kolb EA; Gamis AS; Meshinchi S Clin Cancer Res; 2017 Jul; 23(14):3649-3656. PubMed ID: 28108543 [No Abstract] [Full Text] [Related]
27. Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. Langer C; Marcucci G; Holland KB; Radmacher MD; Maharry K; Paschka P; Whitman SP; Mrózek K; Baldus CD; Vij R; Powell BL; Carroll AJ; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD J Clin Oncol; 2009 Jul; 27(19):3198-204. PubMed ID: 19451432 [TBL] [Abstract][Full Text] [Related]
28. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis. Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248 [TBL] [Abstract][Full Text] [Related]
29. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia. Shiba N; Ichikawa H; Taki T; Park MJ; Jo A; Mitani S; Kobayashi T; Shimada A; Sotomatsu M; Arakawa H; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y Genes Chromosomes Cancer; 2013 Jul; 52(7):683-93. PubMed ID: 23630019 [TBL] [Abstract][Full Text] [Related]
30. Acute myeloid leukemia with NUP98-HOXC13 fusion and FLT3 internal tandem duplication mutation: case report and literature review. Tosić N; Stojiljković M; Colović N; Colović M; Pavlović S Cancer Genet Cytogenet; 2009 Sep; 193(2):98-103. PubMed ID: 19665070 [TBL] [Abstract][Full Text] [Related]
31. Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan. Miyamura T; Kudo K; Tabuchi K; Ishida H; Tomizawa D; Adachi S; Goto H; Yoshida N; Inoue M; Koh K; Sasahara Y; Fujita N; Kakuda H; Noguchi M; Hiwatari M; Hashii Y; Kato K; Atsuta Y; Okamoto Y Leuk Res; 2019 Dec; 87():106263. PubMed ID: 31707119 [TBL] [Abstract][Full Text] [Related]
32. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression. Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595 [TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia. Tarlock K; Gerbing RB; Ries RE; Smith JL; Leonti A; Huang BJ; Kirkey D; Robinson L; Peplinski JH; Lange B; Cooper TM; Gamis AS; Kolb EA; Aplenc R; Pollard JA; Alonzo TA; Meshinchi S Blood Adv; 2024 May; 8(9):2094-2103. PubMed ID: 38295280 [TBL] [Abstract][Full Text] [Related]
34. Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1. Liu L; Nie Q; Xiao Z; Chen X; Yang C; Mao X; Li N; Zhou Y; Guo Q; Tian X BMC Pediatr; 2024 Jul; 24(1):483. PubMed ID: 39068406 [TBL] [Abstract][Full Text] [Related]
35. Fms-like tyrosine kinase 3 mutations in childhood acute leukemias and their association with prognosis. Karabacak BH; Erbey F; Bayram I; Yilmaz S; Acipayam C; Kilinç Y; Tanyeli A Asian Pac J Cancer Prev; 2010; 11(4):923-7. PubMed ID: 21133602 [TBL] [Abstract][Full Text] [Related]
36. Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns. Guan W; Zhou L; Li Y; Yang E; Liu Y; Lv N; Fu L; Ding Y; Wang N; Fang N; Liu Q; Wang B; Li F; Zhang J; Wang M; Wang L; Jing Y; Li Y; Yu L Exp Hematol Oncol; 2021 Apr; 10(1):27. PubMed ID: 33836835 [TBL] [Abstract][Full Text] [Related]
37. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H; N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602 [TBL] [Abstract][Full Text] [Related]
38. Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia. Staffas A; Kanduri M; Hovland R; Rosenquist R; Ommen HB; Abrahamsson J; Forestier E; Jahnukainen K; Jónsson ÓG; Zeller B; Palle J; Lönnerholm G; Hasle H; Palmqvist L; Ehrencrona H; Blood; 2011 Nov; 118(22):5905-13. PubMed ID: 21967978 [TBL] [Abstract][Full Text] [Related]
39. [Identification of molecular markers in children with acute myeloid leukemia (AML)]. Ilenčíková D; Sýkora J; Mikulášová Z; Repiská V Klin Onkol; 2012; 25(1):26-35. PubMed ID: 22348217 [TBL] [Abstract][Full Text] [Related]
40. Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group. Tarlock K; Alonzo TA; Moraleda PP; Gerbing RB; Raimondi SC; Hirsch BA; Ravindranath Y; Lange B; Woods WG; Gamis AS; Meshinchi S Br J Haematol; 2014 Jul; 166(2):254-259. PubMed ID: 24661089 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]